Form 10 Explorer
10-Q
Quarterly Report
BIO KEY INTERNATIONAL INC

BKYI

NASDAQ

CIK: 1019034

File #: 1-13463

Period End: Mar 31, 2025

Fiscal Year: 2025

View on EDGAR
Balance Sheet
40 line items · 2 periods
XBRL
ItemMar 31, 2025Dec 31, 2024
ASSETS
Cash and cash equivalents
3,133,752437,604
Accounts receivable, net
803,277718,229
Due from factor
40,45074,170
Inventory
357,842378,307
Prepaid expenses and other
254,285278,648
Total current assets
4,589,6061,886,958
Equipment and leasehold improvements, net
122,986140,198
Capitalized contract costs, net
375,705409,426
Deposits and other assets
7,9767,976
Operating lease right-of-use assets
67,14273,372
Approximation
67,67073,372
Investments
5,000,0005,000,000
Intangible assets, net
1,020,2611,097,630
Total non-current assets
6,594,0706,728,602
TOTAL ASSETS
11,183,6768,615,560
LIABILITIES
Accounts payable
568,836818,187
Accrued liabilities
1,042,4111,278,732
Senior Secured Promissory Note
762,1511,525,977
Government Loan
138,667132,731
Deferred revenue, current
928,291773,267
Operating lease liabilities, current portion
25,26024,642
Total current liabilities
3,465,6164,553,536
Deferred revenue, long term
136,931196,237
Government loan – BBVA Bank – net of current portion
11,66644,762
Operating lease liabilities, net of current portion
42,41048,994
Total non-current liabilities
191,007289,993
TOTAL LIABILITIES
3,656,6234,843,529
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 5,814,041 and 3,715,483 of $.0001 par value at March 31, 2025 and December 31, 2024, respectively
582372
Additional paid-in capital
137,514,825133,030,271
Accumulated other comprehensive loss
56,09349,290
Accumulated deficit
(130,044,447)(129,307,902)
TOTAL STOCKHOLDERS’ EQUITY
7,527,0533,772,031
Common Stock
582372
Additional Paid-in Capital
137,514,825133,030,271
AOCI Attributable to Parent
56,09349,290
Retained Earnings
(130,044,447)(129,307,902)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
11,183,6768,615,560